TY - JOUR
T1 - The PROactive innovative conceptual framework on physical activity
AU - the PROactive consortium
AU - Dobbels, Fabienne
AU - De Jong, Corina
AU - Drost, Ellen
AU - Elberse, Janneke
AU - Feridou, Chryssoula
AU - Jacobs, Laura
AU - Rabinovich, Roberto
AU - Frei, Anja
AU - Puhan, Milo A.
AU - de Boer, Pim
AU - Van Der Molen, Thys
AU - Williams, Kate
AU - Pinnock, Hillary
AU - Troosters, Thierry
AU - Karlsson, Niklas
AU - Kulich, Karoly
AU - Rüdell, Katja
AU - Brindicci, Caterina
AU - Higenbottam, Tim
AU - Decramer, Marc
AU - Tabberer, Margaret
AU - MacNee, William
AU - Vogiatzis, Ioannis
AU - Polkey, Michael
AU - Hopkinson, Nick
AU - Garcia-Aymerich, Judith
AU - de Boer, Pim
AU - Jarrod, Ian
AU - McBride, Paul
AU - Kamel, Nadia
AU - Wilson, Frederick J.
AU - Ivanoff, Nathalie
AU - Glendenning, Alistair
AU - Corriol-Rohou, Solange
AU - Nikai, Enkeleida
AU - Erzen, Damijan
N1 - Funding Information:
This study was funded by the Innovative Medicines Initiative Joint Undertaking (IMI-JU) PROactive project (GA#115011).
Publisher Copyright:
© ERS 2014.
PY - 2014
Y1 - 2014
N2 - Although physical activity is considered an important therapeutic target in chronic obstructive pulmonary disease (COPD), what "physical activity" means to COPD patients and how their perspective is best measured is poorly understood. We designed a conceptual framework, guiding the development and content validation of two patient reported outcome (PRO) instruments on physical activity (PROactive PRO instruments). 116 patients from four European countries with diverse demographics and COPD phenotypes participated in three consecutive qualitative studies (63% male, age mean±SD 66±9 years, 35% Global Initiative for Chronic Obstructive Lung Disease stage III-IV). 23 interviews and eight focus groups (n554) identified the main themes and candidate items of the framework. 39 cognitive debriefings allowed the clarity of the items and instructions to be optimised. Three themes emerged, i.e. impact of COPD on amount of physical activity, symptoms experienced during physical activity, and adaptations made to facilitate physical activity. The themes were similar irrespective of country, demographic or disease characteristics. Iterative rounds of appraisal and refinement of candidate items resulted in 30 items with a daily recall period and 34 items with a 7-day recall period. For the first time, our approach provides comprehensive insight on physical activity from the COPD patients' perspective. The PROactive PRO instruments' content validity represents the pivotal basis for empirically based item reduction and validation.
AB - Although physical activity is considered an important therapeutic target in chronic obstructive pulmonary disease (COPD), what "physical activity" means to COPD patients and how their perspective is best measured is poorly understood. We designed a conceptual framework, guiding the development and content validation of two patient reported outcome (PRO) instruments on physical activity (PROactive PRO instruments). 116 patients from four European countries with diverse demographics and COPD phenotypes participated in three consecutive qualitative studies (63% male, age mean±SD 66±9 years, 35% Global Initiative for Chronic Obstructive Lung Disease stage III-IV). 23 interviews and eight focus groups (n554) identified the main themes and candidate items of the framework. 39 cognitive debriefings allowed the clarity of the items and instructions to be optimised. Three themes emerged, i.e. impact of COPD on amount of physical activity, symptoms experienced during physical activity, and adaptations made to facilitate physical activity. The themes were similar irrespective of country, demographic or disease characteristics. Iterative rounds of appraisal and refinement of candidate items resulted in 30 items with a daily recall period and 34 items with a 7-day recall period. For the first time, our approach provides comprehensive insight on physical activity from the COPD patients' perspective. The PROactive PRO instruments' content validity represents the pivotal basis for empirically based item reduction and validation.
UR - http://www.scopus.com/inward/record.url?scp=84965187655&partnerID=8YFLogxK
U2 - 10.1183/09031936.00004814
DO - 10.1183/09031936.00004814
M3 - Article
C2 - 25034563
AN - SCOPUS:84965187655
SN - 0903-1936
VL - 44
SP - 1223
EP - 1233
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 5
ER -